Provided by Tiger Fintech (Singapore) Pte. Ltd.

Plus Therapeutics, Inc.

0.3151
-0.0515-14.05%
Post-market: 0.3059-0.0092-2.92%19:59 EDT
Volume:24.26M
Turnover:7.75M
Market Cap:16.07M
PE:-0.13
High:0.3433
Open:0.3200
Low:0.2974
Close:0.3666
Loading ...

Plus Therapeutics provides business update on CNSide Diagnostics subsidiary

TIPRANKS
·
26 Jun

Plus Therapeutics Provides Business Update on Cnside Diagnostics Subsidiary

THOMSON REUTERS
·
26 Jun

Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 a.m. Et

THOMSON REUTERS
·
26 Jun

BUZZ-Plus Therapeutics jumps after FDA allows co to begin human trials for cancer therapy

Reuters
·
25 Jun

Why Is Plus Therapeutics Stock (PSTV) Up 100% Today?

TIPRANKS
·
25 Jun

Plus Therapeutics Says FDA Clears Reyobiq IND Application for Pediatric Brain Cancer; Shares Up Pre-Bell

MT Newswires Live
·
25 Jun

BRIEF-Plus Therapeutics Announces FDA Clearance Of Its Investigational New Drug Application

Reuters
·
25 Jun

Plus Therapeutics Announces FDA Clearance of Its Investigational New Drug Application Using Reyobiqtm for the Treatment of Childhood Brain Cancer

THOMSON REUTERS
·
25 Jun

Plus Therapeutics announces restructuring of $15M equity financing

TIPRANKS
·
24 Jun

Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing

THOMSON REUTERS
·
24 Jun

Plus Therapeutics Inc - Files Request to Withdraw Resale Registration Statement

THOMSON REUTERS
·
24 Jun

Plus Therapeutics Inc. Secures $50 Million Commitment from Lincoln Park Capital for Common Stock Purchases

Reuters
·
21 Jun

Dow Surges 150 Points; Korn Ferry Earnings Top Views

Benzinga
·
19 Jun

Plus Therapeutics- to Offer 17 Mln Shares of Common Stock by by Lincoln Park Capital Fund, Llc - SEC Filing

THOMSON REUTERS
·
18 Jun

Plus Therapeutics Inc. Announces Agreement to Minimize Dilution from March 2025 Private Placement, Cancels Series A Warrants

Reuters
·
18 Jun

Plus Therapeutics Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with Stockholders' Equity Requirement

Reuters
·
07 Jun

BRIEF-Plus Therapeutics Q1 Net Income USD -17.401 Million

Reuters
·
31 May

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights

THOMSON REUTERS
·
31 May

Plus Therapeutics Q1 Basic EPS USD -1.19

THOMSON REUTERS
·
31 May

Plus Therapeutics Inc expected to post a loss of 15 cents a share - Earnings Preview

Reuters
·
30 May